Eosinopenia in COVID-19: What we missed so far?
- PMID: 33648873
- PMCID: PMC7891077
- DOI: 10.1016/j.jmii.2021.01.013
Eosinopenia in COVID-19: What we missed so far?
Keywords: Bacterial; COVID-19; Eosinophil count; Infection; Viral.
Conflict of interest statement
Declaration of competing interest The authors report no conflicts of interest.
References
-
- Outh R., Boutin C., Gueudet P., Suzuki M., Saada M., Aumaître H. Eosinopenia <100/μL as a marker of active COVID-19: an observational prospective study. J Microbiol Immunol Infect. 2021 http://www.ncbi.nlm.nih.gov/pubmed/33468435 Available at: - PMC - PubMed
-
- Rothenberg M.E. Eosinophilia. N Engl J Med. 1998;338:1592–1600. - PubMed
-
- Davido B., Makhloufi S., Matt M., Calin R., Senard O., Perronne C. Changes in eosinophil count during bacterial infection: revisiting an old marker to assess the efficacy of antimicrobial therapy. Int J Infect Dis. 2017;61:62–66. http://linkinghub.elsevier.com/retrieve/pii/S1201971217301595 Available at: - PubMed
-
- Debray A., Nathanson S., Moulin F., Salomon J., Davido B. Eosinopenia as a marker of diagnosis and prognostic to distinguish bacterial from aseptic meningitis in pediatrics. Eur J Clin Microbiol Infect Dis. 2019;38 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
